Extension Study to Assess the Efficacy and Safety of Repeat Treatment With Rituximab (MabThera) in Participants With Active Rheumatoid Arthritis (RA)
Clinical trial NCT02093026 · COMPLETED
Trial details
- NCT number
- NCT02093026
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2002-08-01
- Primary completion
- 2012-12-01
- Enrollment
- 465
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.